4,438 reports of this reaction
2.6% of all DIGOXIN reports
#3 most reported adverse reaction
DIZZINESS is the #3 most commonly reported adverse reaction for DIGOXIN, manufactured by Advanz Pharma (US) Corp.. There are 4,438 FDA adverse event reports linking DIGOXIN to DIZZINESS. This represents approximately 2.6% of all 169,308 adverse event reports for this drug.
Patients taking DIGOXIN who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for DIGOXIN, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for DIGOXIN:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 4,438 FDA reports for DIGOXIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.6% of all adverse event reports for DIGOXIN, making it one of the most commonly reported side effect.
If you experience dizziness while taking DIGOXIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.